JW (Cayman) Therapeutics Co. Ltd carries a market capitalization of 745.49M, placing it among publicly traded companies globally.
| Market Cap | 745.49M |
| Enterprise Value | N/A |
JW (Cayman) Therapeutics Co. Ltd's stock has declined approximately -34.67153% over the past 52 weeks. The 50-day moving average sits at 2.03, while the 200-day moving average is 2.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | -34.67153% |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 2.67 |
| Average Volume (20 Days) | N/A |